How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

247 results for

Tinea Corporis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis

An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. An Open Label (...) Pharmacokinetic Study of Naftin for Tinea Corporis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02466867 Recruitment Status : Completed First Posted : June 9, 2015 Last Update Posted : October 28, 2016 Sponsor: Merz North America, Inc. Information provided by (Responsible Party): Merz North America, Inc

2014 Clinical Trials

22. Pediatric Subjects With Tinea Corporis

how well the study cream works when applied once a day to affected area of child (where they have ringworm). The results will be compared to those seen with a placebo cream which has no active ingredient. Safety of the cream will also be measured. Condition or disease Intervention/treatment Phase Tinea Corporis Drug: Naftin Cream Drug: Placebo Cream Phase 4 Detailed Description: The objectives of this study are to evaluate the safety and efficacy of Naftin (naftifine hydrochloride) Cream, 2 (...) Identifier: Other Study ID Numbers: MUS90200_4024_1 First Posted: August 28, 2014 Last Update Posted: October 28, 2016 Last Verified: October 2016 Keywords provided by Merz North America, Inc.: Tinea Corporis Ringworm Additional relevant MeSH terms: Layout table for MeSH terms Tinea Dermatomycoses Skin Diseases, Infectious Infection Mycoses Skin Diseases Naftifine Antifungal Agents Anti-Infective Agents

2014 Clinical Trials

23. Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis. Full Text available with Trip Pro

Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis. Luliconazole is a novel topical antifungal imidazole with broad-spectrum and potent antifungal activity. The drug is under clinical development in the United States for management of dermatophytosis with a short-term treatment regimen. The present study was undertaken to investigate the clinical benefit of short-term therapy with luliconazole cream in guinea pig (...) models of tinea corporis and tinea pedis induced with Trichophyton mentagrophytes. The dose-dependent therapeutic efficacy of topical luliconazole cream (0.02 to 1%), measured by macroscopic improvement of skin lesions and by fungal eradication as determined by a culture assay, was demonstrated using a tinea corporis model. The improvement in skin lesions seen with luliconazole cream was observed even at a concentration of 0.02%, and its efficacy at 0.1% was equal to that of 1% bifonazole cream

2012 Antimicrobial Agents and Chemotherapy

24. An Outbreak of Tinea Capitis and Tinea Corporis due to Microsporum Lanosum Full Text available with Trip Pro

An Outbreak of Tinea Capitis and Tinea Corporis due to Microsporum Lanosum 13536919 2000 07 01 2018 12 01 0008-4409 78 8 1958 Apr 15 Canadian Medical Association journal Can Med Assoc J An outbreak of tinea capitis and tinea corporis due to Microsporum lanosum. 579-83 BIRT A R AR eng Journal Article Canada Can Med Assoc J 0414110 0008-4409 OM Dermatitis Disease Outbreaks Humans Microsporum Tinea epidemiology Tinea Capitis 5834:29455:527 RINGWORM/epidemiology 1958 4 15 1958 4 15 0 1 1958 4 15 0

1958 Canadian Medical Association Journal

25. Tinea Corporis (Follow-up)

):529-33. . Media Gallery Annular plaque. Large, erythematous, scaly plaque. Tinea corporis. Courtesy of Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Tinea_corporis.png). Dermatophytosis or ringworm with mildly raised boarder and central clearing. Courtesy of Wikimedia Commons [James Heilman, MD] (https://commons.wikimedia.org/wiki/File:Yeartinfection.JPG). of 4 Tables Contributor Information and Disclosures Author Jack L Lesher, Jr, MD Chief, Professor, Department of Internal Medicine (...) Tinea Corporis (Follow-up) Tinea Corporis Treatment & Management: Medical Care, Surgical Care, Complications Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTQ3My10cmVhdG1lbnQ= processing > Tinea Corporis

2014 eMedicine.com

26. Tinea Corporis (Diagnosis)

and Mycological Study. Indian J Dermatol . 2016 Sep-Oct. 61 (5):529-33. . Media Gallery Annular plaque. Large, erythematous, scaly plaque. Tinea corporis. Courtesy of Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Tinea_corporis.png). Dermatophytosis or ringworm with mildly raised boarder and central clearing. Courtesy of Wikimedia Commons [James Heilman, MD] (https://commons.wikimedia.org/wiki/File:Yeartinfection.JPG). of 4 Tables Contributor Information and Disclosures Author Jack L Lesher, Jr (...) Tinea Corporis (Diagnosis) Tinea Corporis: Practice Essentials, Background, Pathophysiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTQ3My1vdmVydmlldw== processing > Tinea Corporis Updated: Jul 10, 2018

2014 eMedicine.com

27. Tinea Corporis (Overview)

and Mycological Study. Indian J Dermatol . 2016 Sep-Oct. 61 (5):529-33. . Media Gallery Annular plaque. Large, erythematous, scaly plaque. Tinea corporis. Courtesy of Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Tinea_corporis.png). Dermatophytosis or ringworm with mildly raised boarder and central clearing. Courtesy of Wikimedia Commons [James Heilman, MD] (https://commons.wikimedia.org/wiki/File:Yeartinfection.JPG). of 4 Tables Contributor Information and Disclosures Author Jack L Lesher, Jr (...) Tinea Corporis (Overview) Tinea Corporis: Practice Essentials, Background, Pathophysiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTQ3My1vdmVydmlldw== processing > Tinea Corporis Updated: Jul 10, 2018

2014 eMedicine.com

28. Tinea Corporis (Treatment)

):529-33. . Media Gallery Annular plaque. Large, erythematous, scaly plaque. Tinea corporis. Courtesy of Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Tinea_corporis.png). Dermatophytosis or ringworm with mildly raised boarder and central clearing. Courtesy of Wikimedia Commons [James Heilman, MD] (https://commons.wikimedia.org/wiki/File:Yeartinfection.JPG). of 4 Tables Contributor Information and Disclosures Author Jack L Lesher, Jr, MD Chief, Professor, Department of Internal Medicine (...) Tinea Corporis (Treatment) Tinea Corporis Treatment & Management: Medical Care, Surgical Care, Complications Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTA5MTQ3My10cmVhdG1lbnQ= processing > Tinea Corporis

2014 eMedicine.com

29. Tinea corporis in a mixed martial arts fighter Full Text available with Trip Pro

Tinea corporis in a mixed martial arts fighter 23109614 2013 09 23 2018 11 13 1488-2329 185 10 2013 Jul 09 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Tinea corporis in a mixed martial arts fighter. 897 10.1503/cmaj.120813 Bachmeyer Claude C Department of Internal Medicine, Tenon Hospital, Paris, France. claude.bachmeyer@tnn.aphp.fr Buot Geneviève G eng Case Reports Journal Article 2012 10 29 Canada CMAJ 9711805 0820-3946 0 Antifungal Agents (...) AIM IM Adult Antifungal Agents therapeutic use Exanthema diagnosis parasitology Humans Male Martial Arts Tinea diagnosis drug therapy transmission Trichophyton 2012 10 31 6 0 2012 10 31 6 0 2013 9 24 6 0 ppublish 23109614 cmaj.120813 10.1503/cmaj.120813 PMC3707996 J Athl Train. 2010 Jul-Aug;45(4):411-28 20617918 Int J Dermatol. 2010 Oct;49(10):1159-64 20636349 Mycoses. 2011 Jul;54(4):e35-8 20002880

2013 CMAJ : Canadian Medical Association Journal

30. British Association of Dermatologists' guidelines for the management of tinea capitis

; 159:711–13. 23 Gupta AK, Williams JV, Zaman M, Singh J. In vitro pharmacody- namic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients. Med Mycol 2009; 47:796–801. 24 [No authors listed]. Managing scalp ringworm in children. Drug Ther Bull 2007; 45:89–92. 25 Greer DL. Successful treatment of tinea capitis with 2% ketoconaz- ole shampoo. Int J Dermatol 2000; 39:302–4. 26 Dinkela A, Feri e J, Mbata M et al. Ef?cacy of triclosan soap (...) canis. Drugs Exp Clin Res 2002; 28:161–4. 53 Foster KW, Friedlander SF, Panzer H et al. A randomized controlled trial assessing the ef?cacy of ?uconazole in the treatment of pedi- atric tinea capitis. J Am Acad Dermatol 2005; 53:798–809. 54 Dastghaib L, Azizzadeh M, Jafari P. Therapeutic options for the treatment of tinea capitis: griseofulvin versus ?uconazole. J Dermato- log Treat 2005; 16:43–6. 55 Seebacher C, Abeck D, Brasch J et al. Tinea capitis: ringworm of the scalp. Mycoses 2007; 50:218–26

2014 British Association of Dermatologists

31. Tinea Corporis Gladiatorum

: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Tinea Corporis Gladiatorum." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Tinea corporis (disorder) (C0040252) Concepts Disease or Syndrome ( T047 ) ICD10 SnomedCT 186994008 , 154400008 , 84849002 English Ringworm of body , Tinea corporis (disorder) , tinea corporis , tinea corporis (diagnosis (...) ) , Ringworm of the body , tinea body , body ringworm , of body ringworm , corporis tinea , herpes circinatus , body tinea , Ringworm of body (disorder) , Tinea corporis , Tinea circinata , Herpes circinatus , Tinea circinatus , Body tinea , body; ringworm , circinatus; herpes , corporis; tinea , herpes; circinatus , ringworm; body , tinea; corporis Italian Tinea corporis , Dermatofitosi del corpo , Tigna del corpo Dutch ringworm van het lichaam , tinea corporis , circinatus; herpes , corporis; tinea

2015 FP Notebook

32. Tinea Corporis

, ДЕРМАТОМИКОЗ , ДЕРМАТОФИТИИ , ТРИХОФИТОЗ , ЭПИДЕРМОФИТОЗ Croatian Not Translated[Tinea] Polish Liszaj obrączkowy , Grzybica powierzchowna , Liszaj obrębny , Grzybica naskórkowa Hungarian Bőrgomba k.m.n. , Tinea fertőzések , Tinea fertőzés , Tinea k.m.n. , Tinea , trichophytosis fertőzés k.m.n. Norwegian Tinea , Ringorm Derived from the NIH UMLS ( ) Ontology: Tinea corporis (disorder) (C0040252) Concepts Disease or Syndrome ( T047 ) ICD10 SnomedCT 186994008 , 154400008 , 84849002 English Ringworm of body (...) , Tinea corporis (disorder) , tinea corporis , tinea corporis (diagnosis) , Ringworm of the body , tinea body , body ringworm , of body ringworm , corporis tinea , herpes circinatus , body tinea , Ringworm of body (disorder) , Tinea corporis , Tinea circinata , Herpes circinatus , Tinea circinatus , Body tinea , body; ringworm , circinatus; herpes , corporis; tinea , herpes; circinatus , ringworm; body , tinea; corporis Italian Tinea corporis , Dermatofitosi del corpo , Tigna del corpo Dutch ringworm

2015 FP Notebook

33. Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis. Full Text available with Trip Pro

Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis. Tinea corporis is a common superficial dermatophytosis seen in tropical countries. Newer molecules are constantly being introduced for its treatment. Topical clotrimazole is in vogue as the treatment for this condition for a long time. Amorolfine is a comparatively recently introduced drug for topical use in this condition.To assess the effectivity and safety of amorolfine (...) 0.25% cream in patients with tinea corporis, in comparison to clotrimazole 1% cream.Patients presenting with symptoms of tinea corporis were mycologically confirmed for the presence of fungal hyphae. They were randomly divided into two groups: one group received amorolfine and the other received clotrimazole. Treatment duration was for 4 weeks and study duration was for 8 weeks. Evaluation was carried out using the standard clinical parameters on day 1, day 14, day 28 and a follow-up on day 56

2012 Indian journal of dermatology Controlled trial quality: uncertain

34. Tinea Corporis Full Text available with Trip Pro

Tinea Corporis 20476399 2010 06 24 2010 06 24 0041-6193 22 Suppl 1 1953 May The Ulster medical journal Ulster Med J Tinea Corporis. 34-7 eng Journal Article Northern Ireland Ulster Med J 0417367 0041-6193 2010 5 18 6 0 1953 5 1 0 0 1953 5 1 0 1 ppublish 20476399 PMC2479714

1953 The Ulster medical journal

35. Unusually Widespread Tinea Corporis Full Text available with Trip Pro

Unusually Widespread Tinea Corporis 13658161 2000 07 01 2018 12 01 0035-9157 52 5 1959 May Proceedings of the Royal Society of Medicine Proc. R. Soc. Med. Unusually widespread tinea corporis. 371-2 RIDLEY C M CM eng Case Reports Journal Article England Proc R Soc Med 7505890 0035-9157 OM Dermatitis Humans Medical Records Tinea 5936:32129:474 RINGWORM/case reports 1959 5 1 1959 5 1 0 1 1959 5 1 0 0 ppublish 13658161 PMC1869212

1959 Proceedings of the Royal Society of Medicine

36. Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata

Society Study Details Study Description Go to Brief Summary: Background: Tinea imbricata ("tokelau") is a rare form of tinea corporis which is caused by Trichophyton concentricum. It is endemic among the T'boli tribe in Sarangani, Philippines . Temporary remissions, despite antifungal treatment, can be attributed to factors such as genetic susceptibility, widespread poverty, poor hygienic conditions and overcrowding. Limited access to commercial antifungal medications makes the treatment of tinea (...) Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata Senna Alata Leaf Decoction as a Treatment for Tinea Imbricata - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Senna Alata Leaf Decoction

2017 Clinical Trials

37. Tinea Corporis

Tinea Corporis Tinea Corporis - Dermatologic Disorders - MSD Manual Professional Edition Brought to you by The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases The trusted provider of medical information since 1899 SEARCH SEARCH MEDICAL TOPICS Common Health Topics Resources QUIZZES & CASES Quizzes Cases / / / / IN THIS TOPIC OTHER TOPICS IN THIS CHAPTER Test your knowledge Diagnostic Tests for Skin (...) : This is the Professional Version. CONSUMERS: Topic Resources Tinea corporis is a dermatophyte infection of the face, trunk, and extremities. Tinea corporis is a that causes pink-to-red annular (O-shaped) patches and plaques with raised scaly borders that expand peripherally and tend to clear centrally. A rare variant form appears as nummular (circle- or round-shaped) scaling patches studded with small papules or pustules that have no central clearing. Common causes are Trichophyton mentagrophytes, T. rubrum

2013 Merck Manual (19th Edition)

38. Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis

Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01349998 Recruitment Status : Completed First Posted : May 9, 2011 Last Update Posted : January 29, 2013 Sponsor: Tinea Pharmaceuticals

2011 Clinical Trials

39. A Double-Blind Randomized Placebo-Controlled Clinical Trial of Squalamine Ointment for tinea capitis Treatment. Full Text available with Trip Pro

. A significantly (p = 0.03) better hair-growth score, indicating a partial clinical improvement of the tinea capitis lesion, was observed in the patients treated with squalamine compared to those treated with placebo.This three-week squalamine ointment regimen was well tolerated and showed an encouraging partial clinical activity for the treatment of tinea capitis. Further studies are needed to evaluate the efficacy of topical squalamine alone against tinea corporis or in combination with a systemic (...) A Double-Blind Randomized Placebo-Controlled Clinical Trial of Squalamine Ointment for tinea capitis Treatment. Novel treatments against for tinea capitis are needed, and the natural aminosterol squalamine is a potential topical antidermatophyte drug candidate.This phase II randomized double-blind placebo-controlled clinical trial aimed at testing the efficacy and safety of a three-week squalamine ointment regimen for the treatment of tinea capitis.Males aged 6-15 years presenting with tinea

2015 Mycopathologia Controlled trial quality: predicted high

40. Tinea capitis in schoolchildren in a rural area in southern Ethiopia. (Abstract)

of dermatophytoses was more common in males than in females (42.2% and 30.5%, respectively; P = 0.002), and among pupils aged 5-7 years (46.9%; P < 0.001). A total of 159 (prevalence: 24.6%, 95% CI 21.3-28.1) children had tinea capitis, 56 (8.7%) had tinea pedis, 50 (7.7%) had tinea corporis, and six (0.9%) had tinea unguium. In multivariate analysis, the risk factors for tinea capitis were: age (odds ratio [OR] 0.75, 95% CI 0.69-0.84; P < 0.001), and male gender (OR 2.56, 95% CI 1.69-13.39; P = 0.002).Fungal (...) Tinea capitis in schoolchildren in a rural area in southern Ethiopia. Skin diseases, especially tinea capitis, represent some of the most frequent causes of morbidity in developing countries. The aim of this study was to examine the prevalences of fungal infections in schoolchildren in a primary school located in a rural area in southern Ethiopia and to perform an analysis of the risk factors associated with tinea capitis.This school-based, prospective cross-sectional study was conducted

2014 International Journal of Dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>